ImportRefusal LogoImportRefusal

Glaxosmithkline Consumer Healthcare

⚠️ Moderate Risk

FEI: 3003277970 • Ermington, NSW • AUSTRALIA

FEI

FEI Number

3003277970

📍

Location

Ermington, NSW

🇦🇺

Country

AUSTRALIA
🏢

Address

82 Hughes Avenue, , Ermington, NSW, Australia

Moderate Risk

FDA Import Risk Assessment

34.2
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
4
Unique Violations
10/19/2018
Latest Refusal
1/24/2008
Earliest Refusal

Score Breakdown

Violation Severity
68.0×40%
Refusal Volume
22.3×30%
Recency
0.0×20%
Frequency
2.8×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

Refusal History

DateProductViolationsDivision
10/19/2018
60CAY53XYLOMETAZOLINE HCL (ADRENERGIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/13/2018
62GAY18DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/24/2008
63RAY06STANNOUS FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
336INCONSPICU
Seattle District Office (SEA-DO)

Frequently Asked Questions

What is Glaxosmithkline Consumer Healthcare's FDA import refusal history?

Glaxosmithkline Consumer Healthcare (FEI: 3003277970) has 3 FDA import refusal record(s) in our database, spanning from 1/24/2008 to 10/19/2018.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glaxosmithkline Consumer Healthcare's FEI number is 3003277970.

What types of violations has Glaxosmithkline Consumer Healthcare received?

Glaxosmithkline Consumer Healthcare has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Glaxosmithkline Consumer Healthcare come from?

All FDA import refusal data for Glaxosmithkline Consumer Healthcare is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.